Overview

The Tolerability of Alprostadil Liposome for Injection in Healthy Adult Volunteers

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
Conducted in Chinese healthy adult volunteers,the study aims to observe the safety and tolerability of single/multiple-dose administration of different doses of Alprostadil Liposome for Injection as well as to confirm the safety dose range.
Phase:
Phase 1
Details
Lead Sponsor:
Guangzhou Yipinhong Pharmaceutical CO.,LTD
Treatments:
Alprostadil